Published in Cancer on November 13, 2015
Breast cancer risk by the extent and type of atypical hyperplasia. Cancer (2016) 1.08
Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women. Cancer (2016) 1.02
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer. Breast Cancer (Auckl) (2016) 0.77
Reply to breast cancer risk by the extent and type of atypical hyperplasia. Cancer (2016) 0.75
Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy. JAMA Oncol (2017) 0.75
Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med (1998) 12.20
Test of the National Death Index. Am J Epidemiol (1984) 8.46
Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med (1985) 7.22
Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84
Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer (1985) 3.92
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer (1993) 3.33
A prospective study of benign breast disease and the risk of breast cancer. JAMA (1992) 3.29
Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol (2007) 2.58
Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med (1998) 2.38
A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol (1988) 2.20
Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol (2002) 1.91
A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer (1990) 1.81
Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev (1997) 1.75
Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer (1992) 1.51
The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer (2006) 1.44
Prognostic significance of benign proliferative breast disease. Cancer (1993) 1.42
Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer (2007) 1.36
A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control (2010) 1.35
Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol (1992) 1.17
Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res (Phila) (2014) 1.13
Chronic mastopathy and breast cancer. A follow-up study. Cancer (1977) 1.09
The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. J Cancer Res Clin Oncol (2011) 1.03
Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer (1991) 0.93
Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium. Am J Surg (2013) 0.81
Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. Cancer Res (2016) 0.77
Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status. Cancer Epidemiol Biomarkers Prev (2015) 0.77
Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies. Cancer Prev Res (Phila) (2016) 0.75
Reply to breast cancer risk by the extent and type of atypical hyperplasia. Cancer (2016) 0.75